Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
Public ClinicalTrials.gov record NCT01948882. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Multi-National Clinical Study to Evaluate the Safety and Effectiveness of the Essure® (Model ESS505) Device to Prevent Pregnancy in Women Who Are Seeking Permanent Contraception
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Essure System is indicated for women who desire non-incisional permanent birth control (female sterilization) by occlusion of the fallopian tubes. The objective of the study is to evaluate the safety and effectiveness of the Essure System (Model ESS505) for permanent birth control in preventing pregnancy. The Essure ESS505 System includes a design modification that will be studied to determine if it provides immediate birth control, thereby removing the three months waiting period required for the commercially available Essure System Model 305 to be effective.
Study identification
- NCT ID
- NCT01948882
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 660 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 44 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2013 (Actual)
- Primary completion
- Sep 16, 2015 (Actual)
- Completion
- Sep 12, 2024 (Actual)
- Last update posted
- Oct 17, 2024
2013 – 2024
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Denver | Colorado | 80231 | — |
| Not listed | Wellington | Florida | 33414 | — |
| Not listed | Fort Wayne | Indiana | 46825 | — |
| Not listed | Newburgh | Indiana | 47630 | — |
| Not listed | Saginaw | Michigan | 48604 | — |
| Not listed | Rochester | Minnesota | 55905 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | The Bronx | New York | 10467 | — |
| Not listed | Asheville | North Carolina | 28801 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Columbia | Ohio | 60004 | — |
| Not listed | Dallas | Texas | 75208 | — |
| Not listed | Houston | Texas | 77074 | — |
| Not listed | Irving | Texas | 75062 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01948882, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2024 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01948882 live on ClinicalTrials.gov.